About Xcell Biosciences
Xcell Biosciences is a private company based in San Francisco, California. It has reported $28,407,253 raised in three offerings on Form D since February 2017. Its chief executive is Brian Feth.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 6, 2024 | Dec 17, 2024 | $1,400,000of $3.5M target | 5 | $280K | EquityRule 506(b) | Form D ↗ |
| Aug 11, 2021 | Sep 13, 2021 | $15,488,682of $24.9M target | 15 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Jan 24, 2017 | Feb 23, 2017 | $11,518,571of $11.9M target | 33 | $349K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $28,407,253 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Xcell Biosciences's Form D filed Dec 17, 2024.
SA
Saeid Akhtari
Director
JL
James Lim
Executive officer
KO
Kaz Ohno
Executive officer
BF
Brian Feth
Chief Executive Officer and director